Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2008/11/01
-
Indian UGC (journal)
-
Refrences197
-
Citations412
-
Elliott J Mufson
-
Scott E Counts
-
Sylvia E Perez
-
Stephen D Ginsberg
Cite
Mufson, Elliott J, et al. “Cholinergic System During the Progression of Alzheimer’s Disease: Therapeutic Implications”. Expert Review of Neurotherapeutics, vol. 8, no. 11, 2008, pp. 1703-18, https://doi.org/10.1586/14737175.8.11.1703.
Mufson, E. J., Counts, S. E., Perez, S. E., & Ginsberg, S. D. (2008). Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications. Expert Review of Neurotherapeutics, 8(11), 1703-1718. https://doi.org/10.1586/14737175.8.11.1703
Mufson EJ, Counts SE, Perez SE, Ginsberg SD. Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications. Expert Review of Neurotherapeutics. 2008;8(11):1703-18.
Journal Categories
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Neurology
Diseases of the nervous system
Medicine
Therapeutics
Pharmacology
You May Also Like
- Microbiota-Brain-Gut Axis and Neurodegenerative Diseases
- State of the Evidence Traffic Lights 2019: Systematic Review of Interventions for Preventing and Treating Children with Cerebral Palsy
- IDH1 and IDH2 Mutations in Gliomas
- Motor learning: its relevance to stroke recovery and neurorehabilitation
- The epidemiology of epilepsy revisited
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.1016/S0140-6736(08)61074-0 | 2008 | |||
| Galanin – 25 years with a multitalented neuropeptide | Cellular and Molecular Life Sciences |
| 45 | 2008 |
| Galanin – 25 years with a multitalented neuropeptide | Cellular and Molecular Life Sciences |
| 31 | 2008 |
| Galanin – 25 years with a multitalented neuropeptide | Cellular and Molecular Life Sciences |
| 30 | 2008 |
| Insights into the interaction of sortilin with proneurotrophins: A computational approach | Neuropeptides |
| 16 | 2008 |
Refrences Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 220
is the most frequently represented among the references in this article. It primarily includes studies from Annals of Neurology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Ultrasensitive and Multiple Biomarker Discrimination for Alzheimer's Disease via Plasmonic & Microfluidic Sensing Technologies | Advanced Science |
| 2024 | |
| Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways | Ageing Research Reviews |
| 1 | 2024 |
| The relationship between inflammation, impaired glymphatic system, and neurodegenerative disorders: A vicious cycle | Neurobiology of Disease |
| 1 | 2024 |
| Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: Implications for alzheimer's disease pathogenesis | Neuroscience & Biobehavioral Reviews |
| 2024 | |
| NLRP3 inflammasome signalling in Alzheimer's disease | Neuropharmacology |
| 2024 |
Citations Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 181
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled In vivo labelling of hippocampal β‐amyloid in triple‐transgenic mice with a fluorescent acetylcholinesterase inhibitor released from nanoparticles and was published in 2009. The most recent citation comes from a 2024 study titled Regulatory roles of microRNAs in modulating mitochondrial dynamics, amyloid beta fibrillation, microglial activation, and cholinergic signaling: Implications for alzheimer's disease pathogenesis. This article reached its peak citation in 2018, with 47 citations. It has been cited in 226 different journals, 24% of which are open access. Among related journals, the International Journal of Molecular Sciences cited this research the most, with 14 citations. The chart below illustrates the annual citation trends for this article.